A new real-world analysis suggests that cardio-kidney-metabolic (CKM) therapies, widely used in type 2 diabetes (T2D), may offer meaningful kidney benefits for patients with type 1 diabetes (T1D) and ...
In this episode, ‘Assessing Clinical and Economic Factors in Treatment Selection and Payer Decision-Making,’ the panelists ...
Following enhanced credit expiration, 80% of continuing Marketplace enrollees reported higher cost sharing year over year, and 51% said costs were “a lot higher.” Financial toxicity concerns were ...
All-urban residence correlated with longer treatment initiation times despite an a priori hypothesis favoring rural delays, suggesting urban-system bottlenecks rather than geographic distance alone.
Linerixibat targets pruritus pathobiology in PBC by blocking ileal bile acid reuptake, aiming to lower circulating pruritogenic bile acid–related mediators. GLISTEN demonstrated greater 24-week WI-NRS ...
The newly approved mosunetuzumab for relapsed/refractory follicular lymphoma improves clinic efficiency and patient experience, says Zahra Mahmoudjafari, PharmD, MBA, BCOP. She also explained how the ...
A >500-patient, randomized, double-blind phase 3 trial showed CT-P43 achieved PASI 75 equivalence at week 12 versus ustekinumab under standard induction and q12w maintenance dosing. Durability through ...
Sanctions are a key tool that states use to hold Medicaid managed care organizations (MCOs) accountable for their use of public funds. The 2023 reports that MCOs submit ...
Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care delivery. Effective multiple sclerosis (MS) treatment requires thinking ...
Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, ...
Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...
NHANES 2017–2018 elastography data (n=4102) linked to mortality showed 59 deaths over ~24 months; decedents were older and more likely to have diabetes. MASLD (CAP ≥274 dB/m) with diabetes carried ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results